Abstract
Background Counterfeit medicines (CFMs) are a global problem with significant and well-documented consequences for global health and patient safety. Pharmacists, as healthcare professionals, have a vital role in combating CFMs via ensuring the effectiveness and safety of any imported and dispensed medicines.
Objectives The aim of the present study was to assess the extent, awareness and attitude of pharmacists in Sudan towards CFMs.
Methods A cross-sectional study was conducted applying pretested and structured questionnaire and the awareness and attitude were assessed statistically.
Results A total of 229 participants have enrolled in the study. The majority of the respondents (76%) were found to be aware about the term CFMs during practice. 59% reported their ability to distinguish CFMs from the packaging feature and cost. Unavailability of medicine and inadequate regulatory bodies control were mentioned as the main leading factors for the spread of CFMs. 86% of the respondents reported knowing that there are pharmacists who deal with counterfeit medicines believing that they are unethical (76%). 69% of the respondents mentioned pharmacists to have vital role in combating CFMs spread through increasing knowledge and education. 62% of the participants were found to have a fair awareness about CFMs. Furthermore, 56% of them showed a good attitude toward CFMs.
Conclusion Current literature includes gaps in knowledge and attitude towards CFMs. Therefore attention and concentrated efforts are required on the part of the government, drug manufacturers and health care providers’ especially pharmaceutical analysts to ensure that only drugs of acceptable quality reach the patient.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research is fully funded by the Ministry of Higher Education and Scientific Research, Sudan
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical Committee (FPEC-03-2019), Faculty of Pharmacy, University of Khartoum.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All dataset supporting this article is available within the article